OncoQuest Pharmaceuticals Inc (078590) — Capital Reinvestment Ratio
Latest as of March 2025:
0.15x
OncoQuest Pharmaceuticals Inc (078590) has a Capital Reinvestment Ratio of 0.15x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩431.70 Million) in capital expenditures (₩62.84 Million). See 078590 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.15x
Capex / Operating Cash Flow
Operating Cash Flow
₩431.70 Million
KRW
Capital Expenditures
₩62.84 Million
KRW
Data as of
Mar 2025
Most recent filing
OncoQuest Pharmaceuticals Inc Capital Reinvestment Ratio (2014–2025)
This chart tracks OncoQuest Pharmaceuticals Inc's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year Capital Reinvestment Ratio for OncoQuest Pharmaceuticals Inc from 2014 to 2025. For live market cap and broader valuation context, see OncoQuest Pharmaceuticals Inc (078590) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.43x | ₩485.35 Million | ₩1.18 Billion | ▲ +283.1% |
| 2024 | 0.63x | ₩3.96 Billion | ₩2.51 Billion | ▲ +274.4% |
| 2023 | 0.17x | ₩11.19 Billion | ₩1.90 Billion | ▼ -63.1% |
| 2020 | 0.46x | ₩7.55 Billion | ₩3.48 Billion | ▼ -50.1% |
| 2018 | 0.92x | ₩1.44 Billion | ₩1.33 Billion | ▲ +245.5% |
| 2017 | 0.27x | ₩4.79 Billion | ₩1.28 Billion | ▼ -41.2% |
| 2016 | 0.45x | ₩3.54 Billion | ₩1.61 Billion | ▼ -56.4% |
| 2015 | 1.04x | ₩2.79 Billion | ₩2.91 Billion | ▼ -10.4% |
| 2014 | 1.16x | ₩1.02 Billion | ₩1.18 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow